N/A
Completed N=55
Oxytocin Pathways and the Health Effects of Human-Animal Interaction
Human-Animal Bond · Human-Animal Interaction
Source: ClinicalTrials.gov NCT03852264 ↗
Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Salivary Oxytocin, Area Under the Curve — -3.03; -3.83; -5.57 pg/mL x minutes
Summary
This study investigates the roles of oxytocin pathways in human-animal interaction.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Salivary Oxytocin, Area Under the Curve |
-3.03; -3.83; -5.57 | — |
| PRIMARY Urinary Oxytocin, Area Under the Curve |
0.261; -0.219; -0.180 | — |
| SECONDARY Salivary Cortisol, Area Under the Curve |
-99.7; -221.1; -103.0 | — |
| SECONDARY Urinary Vasopressin, Area Under the Curve |
— | — |
Eligibility Criteria
Inclusion Criteria
- Participants in this study will include typically-developing children between 8-10 years who have lived with a companion dog in the household for at least 6 months.
Exclusion Criteria
- known medical diseases or injuries involving the central nervous or endocrine systems, major physical abnormalities, seizures, and significant sensory, cognitive, or motor impairments, current use of psychoactive medications
Data sourced from ClinicalTrials.gov (NCT03852264). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.